Mississauga to be part of pilot project involving AstraZeneca-Oxford vaccine

 

Good news for residents of Mississauga on the vaccine front. 

According to Mayor Bonnie Crombie, Mississauga will be part of a pilot project that will involve eight of the city’s primary care partners administering the AstraZeneca-Oxford vaccine—one of the vaccines recently approved by Health Canada.

As part of the pilot, the vaccine will be administered to residents who are between the ages of 60 and 64 years old. 

According to Crombie, details are still being finalized, and there will be more information coming soon.  

Your Comments